National Comprehensive Cancer Network
- NCCN
Guidelines®- End User License Agreement
- NCCN Guidelines for
Treatment of Cancer by Site- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anal Carcinoma
- Basal and Squamous Cell Skin Cancers
- Bladder Cancer
- Bone Cancer
- Breast Cancer
- Central Nervous System Cancers
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon Cancer
- Dermatofibrosarcoma Protuberans
- Esophageal and Esophagogastric Junction Cancers
- Gastric Cancer
- NCCN Guidelines for Detection,
Prevention, & Risk Reduction - NCCN Guidelines for
Supportive Care - NCCN Guidelines for
Age Related Recommendations - NCCN Guidelines for Patients®
- International Adaptations & Translations
- NCCN Pocket Guidelines
- NCCN Disclosure Policies &
Potential Conflicts of Interest - Licensing and Permissions
- Stay up-to-date with
NCCN Flash Updates™ - NCCN Guidelines Apps
- NCCN
Compendia- End User License Agreement
- NCCN Compendium®
- NCCN Biomarkers Compendium™
- Subscribe to the NCCN Compendia
- Licensing and Permissions
- Subscriptions
& Products- NCCN Compendium
- NCCN Biomarkers Compendium
- NCCN Templates
- Combination Subscriptions
- NCCN Flash Updates™
- NCCN Flash Updates™ Coupons
- NCCN Trends™ Surveys & Data
- NCCN Academy Video Modules
- NCCN eBulletin Newsletter
- NCCN Health Information Technology Licensees
- JNCCN — Journal of the National Comprehensive Cancer Network
- Advertising Opportunities
- NCCN Online Catalog
- Clinical & Business
Resources- Members Only
- NCCN Corporate Council
- NCCN Academy
- NCCN Insights: Analytics, Research & Consulting
- NCCN Resource Tool: REMS
- NCCN Collaboration with the National Business Group on Health
- NCCN Virtual Reimbursement Resource Room
- NCCN Health Information Technology Licensees
- NCCN Oncology Policy Program White Papers
- NCCN Oncology Research Program (ORP)
- ORP Recent News
- NCCN ORP Affiliate Research Project
- ORP Scientific Publications
- ORP Investigator Steering Committee
- ORP Testimonials
- Clinical Trials at NCCN Member Institutions
- Find ORP Funded Clinical Trials at NCCN Member Institutions
- NCCN Specialized Imaging Research Consortium™ (SIRC)
- NCCN ORP Disclosure Policy
- NCCN ORP for Industry
- NCCN Informed Consent Language Database
- NCCN Content Policies
- Patient
Resources- NCCN Guidelines for Patients®
- NCCN Website for Patients and
Caregivers - NCCN.com - Find an NCCN Member Institution
- Find an NCCN Cancer Center Near You
- Information on Patient Assistance & Reimbursement Help
- NCCN Virtual Reimbursement Resource Room Guide
- Find Clinical Trials
- NCCN Foundation
- Donate to the NCCN Foundation
NCCN Research & Business Resources
NCCN Affiliate Research Project (ARP)
The National Comprehensive Cancer Network® (NCCN®) established the Affiliate Research Project Working Group (ARPWG) in 2010 to develop and implement a project that gives affiliates of NCCN Member Institutions access to cutting-edge research opportunities. The mission of the project is to improve patient outcomes and advance medical science through the quality execution of clinical research conducted through a powerful collaboration among NCCN, NCCN Member Institutions, and their community-based affiliate networks. NCCN's Oncology Research Program (ORP) qualifies sites, offers research opportunities, and oversees all studies.
Approved NCCN Member Institution Affiliates:
Fox Chase Cancer Center, Philadelphia, PA
- Virtua, includes:
Hematology Oncology Associates of South Jersey, Mt. Holly, NJ
Comprehensive Cancer and Hematology Specialists, Voorhees, NJ
Principal Investigator: Michael Entmacher, MD
- AtlantiCare Cancer Care Institute, Egg Harbor Township, NJ
Principal Investigators: Michael J. Kane, MD, FACP & James C. Wurzer, MD, PhD
- South Jersey Healthcare, includes:
Southern Oncology-Hematology Associates, P.A., Vineland, NJ
South Jersey Radiation Oncology, P.C., Vineland, NJ
The Minniti Center—Medical Oncology and Hematology, Mickleton, NJ
Principal Investigator: Kush Sachdeva, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- Bozeman Deaconess Hospital, Bozeman, MT
Principal Investigator: Jack Hensold, MD
- MultiCare Health System, Tacoma, WA
Principal Investigator: John A. Keech Jr., DO, FACIO
- Wenatchee Valley Medical Center, Wenatchee, WA
Principal Investigator: Mitchell Garrison, MD
Moffitt Cancer Center, Tampa, FL
- Norton Healthcare, Louisville, KY
Principal Investigator: John Hamm, MD
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
- Medical Center of Central Georgia, Macon, GA, includes:
Central Georgia Cancer Care, P.C.
Central Georgia Gynecologic Oncology
Central Georgia Radiation Oncology Center
Principal Investigator: Frederick Schnell, MD
*Listing as of 10/9/2012
For additional information on the NCCN Affiliate Research Project, please contact the NCCN ORP at 215.690.0571 or ORP@nccn.org.
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved